Literature DB >> 26404516

The disease recurrence rate after the canal wall up or canal wall down technique in adults.

Kelly G P Kerckhoffs1, Maarten B J Kommer1, Thom H L van Strien1, Simeon J A Visscher1, Hanneke Bruijnzeel1,2, Adriana L Smit1, Wilko Grolman1,2.   

Abstract

OBJECTIVES/HYPOTHESIS: To review which type of cholesteatoma surgery, canal wall up (CWU) or canal wall down (CWD), provides the lowest risk for residual and/or recurrent disease in adults with primary acquired cholesteatoma. DATA SOURCES: PubMed, Embase, CINAHL, the Cochrane Library, Scopus and Web of Science. STUDY
DESIGN: We selected articles comparing CWU with CWD, reporting on disease recidivism (combined residual and recurrent disease) or independent residual or disease recurrence rates. We included studies with a moderate to high relevance.
RESULTS: Our search yielded 2,060 articles. We selected seven studies that carried a moderate risk of bias. Six studies described higher disease recidivism after the CWU procedure [16.7-61.0%] compared to the CWD technique [0-13.2%]. Four studies showed statistical significant difference (P < .05). One study showed opposite results: recidivism was found in 7.8% CWU and in 22.1% CWD cases (P < .001). Studies showed CWU recidivism more likely to be residual disease, whereas CWD recidivism tended to be recurrent disease.
CONCLUSION: The majority of included studies showed CWU to result in more disease recidivism compared to the CWD technique in adult patients with a primary acquired cholesteatoma. If recidivism risk is the most important factor to consider a certain surgical technique, we recommend application of the CWD procedure. However, many additional factors in patient care will define the best treatment decision, such as residual hearing and access to health care. Our recommendations are based on Level II evidence, which underlines the need for future high-level evidence studies.
© 2015 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Cholesteatoma; canal wall down; canal wall up; hearing loss; hearing outcome; recurrence; residual disease

Mesh:

Year:  2015        PMID: 26404516     DOI: 10.1002/lary.25591

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  20 in total

1.  A Novel Surgery Classification for Endoscopic Approaches to Middle Ear Cholesteatoma.

Authors:  Yu Sun; En-Hao Wang; Jin-Tao Yu; Gang Zhong; Li-Xin Zhu; Yi Wang; Niu Xun; Hong Yu; Wen Zhou; Zhen Xie; Kun Zhang; Guo-Run Fan; Yi Zhong; Hong-Jun Xiao; Wei-Jia Kong
Journal:  Curr Med Sci       Date:  2020-03-13

2.  Rapid diffusion-weighted MRI for the investigation of recurrent temporal bone cholesteatoma.

Authors:  Richard G Kavanagh; Stephen Liddy; Anne G Carroll; Yvonne M Purcell; Anna E Smyth; S Guan Khoo; Graeme McNeill; Dermot E Malone; Ronan P Killeen
Journal:  Neuroradiol J       Date:  2020-04-27

3.  Correlation between Surgical Outcome and Stage of Acquired Middle Ear Cholesteatoma: Revalidation of the EAONO/JOS Staging System.

Authors:  Fazıl Necdet Ardıç; Erdem Mengi; Funda Tümkaya; Cüneyt Orhan Kara; Ferda Bir
Journal:  J Int Adv Otol       Date:  2020-04       Impact factor: 1.017

4.  Improved Assessment of Middle Ear Recurrent Cholesteatomas Using a Fusion of Conventional CT and Non-EPI-DWI MRI.

Authors:  F Felici; U Scemama; D Bendahan; J-P Lavieille; G Moulin; C Chagnaud; M Montava; A Varoquaux
Journal:  AJNR Am J Neuroradiol       Date:  2019-08-14       Impact factor: 3.825

5.  Predictive Role of Ki-67 and Proliferative-Cell Nuclear Antigen (PCNA) in Recurrent Cholesteatoma.

Authors:  Ela Araz Server; Çiğdem Kalaycık Ertugay; Sevim Baykal Koca; Ecem Sevim Longur; Özgür Yiğit; Hasan Demirhan; Yasemin Çakır
Journal:  J Int Adv Otol       Date:  2019-04       Impact factor: 1.017

6.  Mastoid obliteration with hydroxyapatite vs. bone pâté in mastoidectomy surgery performed on patients with cholesteatoma and chronic suppurative otitis media: a retrospective analysis.

Authors:  Jantine J Lindeboom; P M W van Kempen; J Buwalda; B O Westerlaken; D A van Zuijlen; S J H Bom; F B van der Beek
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-09-29       Impact factor: 3.236

7.  Treatment of cholesteatoma with intact ossicular chain: anatomic and functional results.

Authors:  V Pontillo; F Barbara; V DE Robertis; N Quaranta
Journal:  Acta Otorhinolaryngol Ital       Date:  2018-02       Impact factor: 2.124

8.  Revision canal-wall down surgery: comparison of surgical outcomes with three different techniques.

Authors:  Matteo Fermi; Till Siggemann; Claudio Melchiorri; Marco Bonali; Laura Niederhauser; Marco Caversaccio; Livio Presutti; Lukas Anschuetz
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-04-27       Impact factor: 2.503

9.  Implantation of the Bonebridge BCI 602 after Mastoid Obliteration with S53P4 Bioactive Glass: A Safe Method of Treating Difficult Anatomical Conditions-Preliminary Results.

Authors:  Bartłomiej Król; Katarzyna Beata Cywka; Magdalena Beata Skarżyńska; Piotr Henryk Skarżyński
Journal:  Life (Basel)       Date:  2021-04-22

10.  Chronic Draining Ear and Cholesteatoma Recidivism: A Retrospection from Clinical, Imaging, and Surgical Perspectives.

Authors:  Saumik Das; Mainak Dutta; Tanaya Panja; Ramanuj Sinha
Journal:  Turk Arch Otorhinolaryngol       Date:  2019-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.